Eli Lilly and Co.

Eli Lilly to buy European rights to Pfizer animal products

March 8, 2010
Scott Olson
The acquisition will benefit Elanco, Lilly's animal health division in Greenfield, which has become increasingly important to Lilly as it braces for patent-protection losses.
More

Market surge doesn't lift Lilly EndowmentRestricted Content

March 6, 2010
Kathleen McLaughlin
Lilly Endowment's resistance to diversify its holdings reached a new height last year, as it failed to sell a single share of the underperforming Eli Lilly and Co. stock while the broader market surged.
More

Three Indiana companies among world's most admired

March 5, 2010
Brightpoint, WellPoint and Cummins are recognized by Fortune magazine as being among the best in their industries.
More

Cornelius to retire as Bristol-Myers Squibb CEO

March 3, 2010
 IBJ Staff and Associated Press
The former Guidant Corp. CEO and long-time Eli Lilly exec said he and his family will be returning to Indianapolis.
More

To attack costs, Lilly accelerates R&D

March 3, 2010
J.K. Wall
With President Barack Obama looking to squeeze a bit more revenue out of the pharmaceutical industry, the stakes just keep getting higher for Eli Lilly and Co.'s efforts to develop drugs faster and cheaper.
More

Lilly to shift more employees to Covance

February 26, 2010
J.K. Wall
Greenfield Labs operation expects to add 17 Eli Lilly and Co. workers after taking over staff of 264 in 2008 acquisition.
More

Obama health reform plan slaps drugmakers

February 24, 2010
J.K. Wall
Drugmakers, such as Indianapolis-based Eli Lilly and Co., would shoulder $3.3 billion in fees, face ban on pay-for-delay deals with generic competitor.
More

Lilly, Merck, Pfizer starting research center

February 23, 2010
Associated Press
Three major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
More

WellPoint gets tax delay in Obama health plan

February 22, 2010
Bloomberg News
Insurers WellPoint Inc. and others would get a delay in taxes on premiums and high-cost medical benefits, along with additional funding for expanding Medicaid, under a White House proposal
More

Lilly asks shareholders to lower takeover barrier

February 20, 2010
J.K. Wall
Eli Lilly and Co. directors have recommended that shareholders toss out the drugmaker's most potent protection against unwanted takeovers: an 80-percent supermajority vote threshold for any shareholder mutiny to succeed.
More

Teva gets European OK to sell generic of Lilly's Evista

February 19, 2010
Bloomberg News
Evista generated $1.03 billion in sales last year, of which $348.1 million came outside the United States.
More

Pfizer's Viagra patent partially rejected in Lilly fight

February 16, 2010
Bloomberg News
The patent on impotence drug Viagra was partially rejected after the U.S. Patent and Trademark Office said it wasn't different enough from a Chinese herb known as Horny Goat Weed. The patent was key to an infringement suit Pfizer filed in 2002 against Eli Lilly and Co. over its rival Cialis drug.
More

Lilly awards pay increases to top executives

February 8, 2010
Peter Schnitzler, J.K. Wall
Eli Lilly and Co. CEO John Lechleiter's total compensation increased $4.1 million in 2009.
More

Mississippi settles Zyprexa suit against Lilly for over $18M

February 4, 2010
Associated Press
Mississippi will receive $18.5 million from Indianapolis-based drugmaker Eli Lilly and Co. as part of a settlement over claims the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat.
More

Q&A: Dr. Kristine Courtney

February 3, 2010
J.K. Wall
Dr. Kristine Courtney, Eli Lilly and Co.’s senior director of corporate health services, describes how and why the company spent two years making its clinics some of the first to electronically swap patient records with a local hospital database.
More

Lilly shares trade down after fourth-quarter profits falls

January 28, 2010
J.K. Wall
Analysts worry about dive in already paltry sales of new blood thinner Effient
More

Lilly's profits fall, miss analyst expectations

January 28, 2010
J.K. Wall
The Indianapolis-based drugmaker says a weaker dollar depressed earnings in the fourth quarter compared with a year ago.
More

Lilly looks to autoimmune drugs

January 27, 2010
J.K. Wall
Two local researchers show why Eli Lilly and Co. and its peers are interested in developing medicines to treat automimmune diseases: The costs of treating them are growing twice as fast as the prescription drug market.
More

Lilly shares get boost from OK of rival's drug

January 26, 2010
 IBJ Staff and Bloomberg News
Shares of Lilly and partner Amylin rose on hopes that their new version of Byetta will be approved following U.S. regulators' clearance of a similar drug.
More

Biotech firm plans $28M Greenwood plant

January 19, 2010
Greenwood pharmaceutical firm Elona Biotechnologies plans to build a $28 million production facility and create 70 jobs to help develop a cheaper form of insulin that could gain significant market share.
More

FDA letters scold Lilly, others over marketing materials

January 13, 2010
Associated Press
The letter to Indianapolis-based Lilly cites a print advertisement for the antidepressant Cymbalta that did not adequately display information about the drug's side effects.
More

FDA cancels meeting to review Lilly's Cymbalta

January 5, 2010
Associated Press
The agency said the meeting was canceled "to allow time for the FDA to review new information" about a proposed new use for the drug.
More

Ruth Lilly remembered for 'selfless' giving

December 31, 2009
Andrea Muirragui Davis
Lilly, 94, who died Wednesday, gave away hundreds of millions of dollars of her fortune during her lifetime.
More

Eli Lilly and Co. heiress Ruth Lilly dies at 94

December 31, 2009
Associated Press
Over the course of her life, the last surviving great-grandchild of pharmaceutical magnate Eli Lilly gave away much of her inheritance.
More

Corporations bet on insiders to bend reform

December 30, 2009
J.K. Wall
Indianapolis health care heavyweights are among those spending $635 million, employing 166 former aides to key congressional leaders and committees in health reform process.
More
Page  << 11 12 13 14 15 16 17 18 19 20 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
  1. Cramer agrees...says don't buy it and sell it if you own it! Their "pay to play" cost is this issue. As long as they charge customers, they never will attain the critical mass needed to be a successful on company...Jim Cramer quote.

  2. My responses to some of the comments would include the following: 1. Our offer which included the forgiveness of debt (this is an immediate forgiveness and is not "spread over many years")represents debt that due to a reduction of interest rates in the economy arguably represents consideration together with the cash component of our offer that exceeds the $2.1 million apparently offered by another party. 2. The previous $2.1 million cash offer that was turned down by the CRC would have netted the CRC substantially less than $2.1 million. As a result even in hindsight the CRC was wise in turning down that offer. 3. With regard to "concerned Carmelite's" discussion of the previous financing Pedcor gave up $16.5 million in City debt in addition to the conveyance of the garage (appraised at $13 million)in exchange for the $22.5 million cash and debt obligations. The local media never discussed the $16.5 million in debt that we gave up which would show that we gave $29.5 million in value for the $23.5 million. 4.Pedcor would have been much happier if Brian was still operating his Deli and only made this offer as we believe that we can redevelop the building into something that will be better for the City and City Center where both Pedcor the citizens of Carmel have a large investment. Bruce Cordingley, President, Pedcor

  3. I've been looking for news on Corner Bakery, too, but there doesn't seem to be any info out there. I prefer them over Panera and Paradise so can't wait to see where they'll be!

  4. WGN actually is two channels: 1. WGN Chicago, seen only in Chicago (and parts of Canada) - this station is one of the flagship CW affiliates. 2. WGN America - a nationwide cable channel that doesn't carry any CW programming, and doesn't have local affiliates. (In addition, as WGN is owned by Tribune, just like WTTV, WTTK, and WXIN, I can't imagine they would do anything to help WISH.) In Indianapolis, CW programming is already seen on WTTV 4 and WTTK 29, and when CBS takes over those stations' main channels, the CW will move to a sub channel, such as 4.2 or 4.3 and 29.2 or 29.3. TBS is only a cable channel these days and does not affiliate with local stations. WISH could move the MyNetwork affiliation from WNDY 23 to WISH 8, but I am beginning to think they may prefer to put together their own lineup of syndicated programming instead. While much of it would be "reruns" from broadcast or cable, that's pretty much what the MyNetwork does these days anyway. So since WISH has the choice, they may want to customize their lineup by choosing programs that they feel will garner better ratings in this market.

  5. The Pedcor debt is from the CRC paying ~$23M for the Pedcor's parking garage at City Center that is apprased at $13M. Why did we pay over the top money for a private businesses parking? What did we get out of it? Pedcor got free parking for their apartment and business tenants. Pedcor now gets another building for free that taxpayers have ~$3M tied up in. This is NOT a win win for taxpayers. It is just a win for Pedcor who contributes heavily to the Friends of Jim Brainard. The campaign reports are on the Hamilton County website. http://www2.hamiltoncounty.in.gov/publicdocs/Campaign%20Finance%20Images/defaultfiles.asp?ARG1=Campaign Finance Images&ARG2=/Brainard, Jim

ADVERTISEMENT